These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1100222)

  • 1. In vitro determination of tritiated thymidine labeling index (LI). Evaluation of a method utilizing hyperbaric oxygen and observations on the LI of human mammary carcinoma.
    Meyer JS; Bauer WC
    Cancer; 1975 Oct; 36(4):1374-80. PubMed ID: 1100222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetics in vivo and in vitro for C3H/He spontaneous mammary tumors.
    Braunschweiger PG; Poulakos L; Schiffer LM
    J Natl Cancer Inst; 1977 Oct; 59(4):1197-204. PubMed ID: 903995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of cellular proliferation in normal and malignant tissues. II. An in vitro method for incorporation of tritiated thymidine in human tissues.
    Fabrikant JI; Wisseman CL; Vitak MJ
    Radiology; 1969 May; 92(6):1309-20. PubMed ID: 4892837
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo labelling of animal tumours with tritiated thymidine.
    Denekamp J; Kallman RF
    Cell Tissue Kinet; 1973 May; 6(3):217-27. PubMed ID: 4700041
    [No Abstract]   [Full Text] [Related]  

  • 5. Density centrifugation of murine fibrosarcoma cells following in situ labelling with tritiated thymidine.
    Sigdestad CP; Grdina DJ
    Cell Tissue Kinet; 1981 Nov; 14(6):589-600. PubMed ID: 7296625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of tritiated thymidine labeling index by incubation in vitro of surgically removed cervical cancer.
    Sasaki K
    Gan; 1977 Jun; 68(3):307-13. PubMed ID: 913953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei.
    Meyer JS; Connor RE
    Stain Technol; 1977 Jul; 52(4):185-95. PubMed ID: 143737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.
    Straus MJ; Moran R; Muller RE; Wotiz HH
    Oncology; 1982; 39(4):197-200. PubMed ID: 7088469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for determination of colonic mucosal proliferation: uptake of tritiated thymidine under hyperbaric oxygen conditions.
    Wargovich MJ; Hu PJ
    Cancer Lett; 1988 Nov; 42(3):207-12. PubMed ID: 3191472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic parameters and the course of the disease in breast cancer.
    Tubiana M; Pejovic MJ; Renaud A; Contesso G; Chavaudra N; Gioanni J; Malaise EP
    Cancer; 1981 Mar; 47(5):937-43. PubMed ID: 7226045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
    Meyer JS; Koehm SL; Hughes JM; Higa E; Wittliff JL; Lagos JA; Manes JL
    Cancer; 1993 Jun; 71(11):3531-40. PubMed ID: 8490901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambiguity of the thymidine index.
    Simpson-Herren L; Sanford AH; Holmquist JP; Springer TA; Lloyd HH
    Cancer Res; 1976 Dec; 36(12):4705-9. PubMed ID: 1000512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors.
    Braunschweiger PG; Poulakos L; Schiffer LM
    Cancer Res; 1976 May; 36(5):1748-53. PubMed ID: 1268832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of the labelling index in tumour studies.
    Hamilton E; Dobbin J
    Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.
    Meyer JS; Hixon B
    Cancer Res; 1979 Oct; 39(10):4042-7. PubMed ID: 476641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties and radiosensitivity of tumours: determination of the cell-cycle and time of synthesis of deoxyribonucleic acid using tritiated thymidine and autoradiography.
    Goldfeder A
    Nature; 1965 Aug; 207(997):612-4. PubMed ID: 5883636
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA synthesis of human, mouse, and rat mammary carcinomas in vitro: influence of insulin and prolactin.
    Welsch CW; Iturri GC; Brennan MJ
    Cancer; 1976 Sep; 38(3):1272-81. PubMed ID: 986235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA synthesis of benign human breast tumors in the untreated athymic "nude" mouse. An in vivo model to study hormonal influences on growth of human breast tissues.
    McManus MJ; Welsch CW
    Cancer; 1980 Apr; 45(8):2160-5. PubMed ID: 7370957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.